M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Corcept Therapeutics Incorporated names Daniel M Bradbury to board
Pharmaceutical company Corcept Therapeutics Incorporated (NASDAQ:CORT) revealed on Monday the appointment of Daniel M Bradbury to its board of directors.
Most recently, Bradbury served as CEO of Amylin Pharmaceuticals Inc from March 2007 until its acquisition by Bristol-Myers Squibb...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives